Choose a folder
DISCOVER takes the stage at IDF 2017
Data presented by the DISCOVER team prompted lively discussions at the 2017 International Diabetes Federation (IDF) congress on 4–8 December in Abu Dhabi, UAE.
This year’s 2017 IDF congress was a great success for DISCOVER! The DISCOVER team was very excited to share our data with the healthcare professionals, academics and policy makers who attended the IDF congress this year. DISCOVER Scientific Committee members Prof. Linong Ji, Prof. Kamlesh Khunti and Prof. Mikhail Kosiborod gave a series of talks about the study rationale and methodology, and presented baseline data on glycaemic control, complications and treatment patterns. The presentations, which took place during the session titled ‘Latest diabetes clinical trials’, included a Q&A session led by Prof. Naveed Sattar that allowed the presenters to expand on the study findings and to share their thoughts about the future of DISCOVER.
Prof Sattar: Gentlemen, were any of you surprised by any of the findings?
Prof Kosiborod: I’m not sure if surprised is the right word – more like [the results were] ‘unexpected’ – but participants in this study were relatively young, with relatively short duration of diabetes, and still we saw complication rates that are quite high. We’re used to seeing high event rates in diabetes CVOTs, which specifically select for high-risk patients. DISCOVER enrolled a very, very different patient population. There was no requirement for individuals to have vascular disease at baseline, and overall, these patients would be considered low-risk. So, are we missing the boat? Are we thinking of these patients as low-risk when in fact they aren’t? What can we do to minimize the risk of complications? Very shortly, we’ll have 1-year data from DISCOVER, and this will be one of the most insightful takeaways.
Prof Khunti: My surprise was that we go to all these diabetes meetings, and we look at these fantastic RCTs showing how we can improve care, but this global population is not receiving the basic care they need. Look at lipids, albuminuria. These are basic standards of care that every patient in the world should get.”
Additionally, Prof. Linong Ji presented an oral poster on hypoglycaemia, which you can read about here. Prof. Kamlesh Khunti also gave a talk including DISCOVER data during a second session titled ‘Access to care and medicines’, which reinforced the presence of DISCOVER at IDF.
The DISCOVER investigator meeting was held on Tuesday 5 December during the IDF congress. Presentations of the data given by the DISCOVER team led to constructive discussions about the progress of the study, the publications plan for 2018 and strategies to continue making DISCOVER a success. The Scientific Committee looks forward to building on these results during the follow-up period to help improve the quality of care for people with type 2 diabetes.
More information about DISCOVER presentations and publications can be found on the DISCOVER website here.